SEC 13F Intelligence

Columbus Hill Capital Management, L.P. / CELG

Columbus Hill Capital Management, L.P.’s Celgene Corp Position

Does Columbus Hill Capital Management, L.P. own Celgene Corp (CELG)? Not currently — the last reported position was 140.2K shares worth $13M in Q1 2019; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$13M
Q1 2019
Shares
140.2K
% of Portfolio
+1.20%
Quarters Held
1
position exited

Position History CELG

Reported value by quarter
Q1 ’19: $13MQ1 ’19filingsflow.com
QuarterSharesValue% of Portfolio
Q1 2019140.2K$13M+1.20%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Columbus Hill Capital Management, L.P.’s full portfolio or all institutional holders of CELG.